REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/04/2025
Voltar para busca
Dado oficial do USPTO
CRESCITA THERAPEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
CRESCITA THERAPEUTICS
ST13
US500000086882764Classe
42
Pedido
86882764
Registro
6026312
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
66
Atualização mais recente
08/04/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42
Data de depósito
21/01/2016
Data de registro
07/04/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/04/2020
Última transação
08/04/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
MISSISSAUGA, CA
Examinador
WATTS-FITZGERALD, CAITLIN
Unidade examinadora
M20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
CRESCITA THERAPEUTICS INC.
Nuvo Research Inc.
Representantes
Gary P. Oakeson THORPE NORTH & WESTERN LLP
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Research and development services in the fields of pharmaceuticalscosmeticsdrug products; conducting pre-clinical trials and clinical trials for others of pharmaceuticalscosmeticsdrug products; the research and development of pharmaceuticalscosmeticsdrug products; research and development in the field of pharmaceuticals; research and development in the field of biotechnology; research and development in the field of cosmetics; pharmaceuticalcosmeticdrug development; providing information about pharmaceuticalcosmeticdrug products; medical and scientific research; consulting services in the fields of pharmaceutical research and developmentcosmetic research and developmentbiotechnology research and developmentpharmaceutical drug developmentmedical and scientific research; conducting pre-clinical and clinical trials for others
Publicações
Histórico de despachos e eventos da marca no USPTO.
66 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
07/04/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/01/2020
PUBO
PUBLISHED FOR OPPOSITION
21/01/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/01/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
17/12/2019
ALIE
ASSIGNED TO LIE
09/12/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/11/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
22/11/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
22/11/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
22/11/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
22/11/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/11/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/11/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/11/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/05/2019
GNRT
NON-FINAL ACTION E-MAILED
10/05/2019
CNRT
NON-FINAL ACTION WRITTEN
10/05/2019
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
29/04/2019
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
16/04/2019
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
29/03/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/03/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/03/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/03/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
13/03/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
13/03/2019
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
08/03/2019
GNSI
INQUIRY TO SUSPENSION E-MAILED
08/03/2019
CNSI
SUSPENSION INQUIRY WRITTEN
08/03/2019
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
08/09/2018
ALIE
ASSIGNED TO LIE
08/09/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/03/2018
GNSL
LETTER OF SUSPENSION E-MAILED
08/03/2018
CNSL
SUSPENSION LETTER WRITTEN
08/03/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/03/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/03/2018
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
28/02/2018
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
22/02/2018
GNSI
INQUIRY TO SUSPENSION E-MAILED
22/02/2018
CNSI
SUSPENSION INQUIRY WRITTEN
22/02/2018
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
20/02/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/08/2017
GNSL
LETTER OF SUSPENSION E-MAILED
11/08/2017
CNSL
SUSPENSION LETTER WRITTEN
11/08/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/08/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/08/2017
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/08/2017
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
26/07/2017
GNSI
INQUIRY TO SUSPENSION E-MAILED
26/07/2017
CNSI
SUSPENSION INQUIRY WRITTEN
26/07/2017
DOCK
ASSIGNED TO EXAMINER
20/07/2017
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
27/06/2017
ALIE
ASSIGNED TO LIE
26/06/2017
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/02/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/12/2016
GNSL
LETTER OF SUSPENSION E-MAILED
06/12/2016
CNSL
SUSPENSION LETTER WRITTEN
06/12/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/11/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/11/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/11/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/05/2016
GNRT
NON-FINAL ACTION E-MAILED
06/05/2016
CNRT
NON-FINAL ACTION WRITTEN
06/05/2016
DOCK
ASSIGNED TO EXAMINER
05/05/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/01/2016
NWAP
NEW APPLICATION ENTERED
25/01/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CRESCITA THERAPEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.